Hyperpigmentation associated with oxprenolol administration.
D005260:Female; D006801:Humans; D008875:Middle Aged; D010096:Oxprenolol / Q000009:adverse effects*; D010859:Pigmentation Disorders / Q000139:chemically induced*
D010096:Oxprenolol